Top-News
  • Depot
  • Watchlist
  • Glocke
  • Handeln

    • Bavarian Nordic News

    19,51 € -2,79% -0,56 €
    25.04.24 19:59:37 Tradegate aktualisieren | Orderbuch | Mehr Kurse »
    WKN: 917165
    ISIN: DK0015998017
    US-Symbol: BVNKF
    Typ: Aktie

    Bavarian Nordic News

    02.04.24 - GlobeNewswire
    Bavarian Nordic Announces Commercial Launch of Mpox Vaccine in the U.S.
    COPENHAGEN, Denmark, April 2, 2024 – Bavarian Nordic A/S (OMX: BAVA) announced today that JYNNEOS ® , the only FDA-​approved mpox vaccine, is now commercially available ...
    13.03.24 - GlobeNewswire
    Bavarian Nordic Receives Approval of Smallpox and Mpox Vaccine in Switzerland
    COPENHAGEN, Denmark, March 13, 2024 – Bavarian Nordic A/S (OMX: BAVA) announced today that the Swiss Agency for Therapeutic Products, Swissmedic, has approved ...
    12.03.24 - GlobeNewswire
    Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
    COPENHAGEN, Denmark, March 12, 2024 – Bavarian Nordic A/S (OMX: BAVA) has today received information about the following transactions of the Company’s shares/related ...
    06.03.24 - GlobeNewswire
    Bavarian Nordic Publishes Annual Report 2023
    COPENHAGEN, Denmark, March 6, 2024 – Bavarian Nordic A/S (OMX: BAVA) today published its Annual Report for 2023. The consolidated, audited results were in line with the ...
    23.02.24 - GlobeNewswire
    Bavarian Nordic’s Chikungunya Vaccine Candidate Granted Accelerated Assessment by European Medicines Agency
    Accelerated assessment allows for a shorter review period with EMA. Bavarian Nordic is on track to submit its Marketing Authorisation Application for CHIKV VLP to EMA during H1 ...
    21.02.24 - GlobeNewswire
    Bavarian Nordic delivered record financial results in 2023
    Preliminary 2023 results exceed the latest guidance and represent the best-ever financial result in the Company’s history driven by extraordinary growth in travel health and a surge in ...
    22.11.23 - GlobeNewswire
    Bavarian Nordic to hold Capital Markets Days in February 2024
    COPENHAGEN, Denmark, November 22, 2023 – Bavarian Nordic A/S (OMX: BAVA) will hold a series of capital markets days in February 2024 for investors and analysts across ...
    16.11.23 - GlobeNewswire
    Bavarian Nordic Announces Interim Results for the First Nine Months of 2023
    COPENHAGEN, Denmark, November 16, 2023 – Bavarian Nordic A/S (OMX: BAVA) announced today its interim financial results for the first nine months of 2023 and business ...
    25.10.23 - GlobeNewswire
    Bavarian Nordic’s Mpox Vaccine Receives Recommendation from U.S. CDC Advisory Committee for Routine Use in Adults at Risk
    COPENHAGEN, Denmark, October 25, 2023 – Bavarian Nordic A/S (OMX: BAVA) announced today that the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory ...
    13.09.23 - GlobeNewswire
    Bavarian Nordic Awarded Another Contract to Supply Smallpox Vaccines for EU Strategic Reserve
    COPENHAGEN, Denmark, September 13, 2023 – Bavarian Nordic A/S (OMX: BAVA) announced today, that it has been awarded another contract valued at more than EUR 11 million ...
    01.09.23 - 4investors
    Bavarian Nordic: Enttäuschung beim COVID-19 Impfstoff
    23.08.23 - 4investors
    Bavarian Nordic Aktie nach Zahlen deutlich im Plus - Vorsicht bleibt aber angebracht
    23.08.23 - Der Aktionär
    Bavarian Nordic: Umsatzexplosion von 278 Prozent – Aktie startet durch – ein weiterer Gewinner
    23.08.23 - GlobeNewswire
    Bavarian Nordic Announces First Half 2023 Results
    COPENHAGEN, Denmark, August 23, 2023 – Bavarian Nordic A/S (OMX: BAVA) announced today its interim financial results and business progress for the first half of 2023 and ...
    24.07.23 - Der Aktionär TV
    Microsoft, Alphabet, AMC Entertainment, Snap, Shopify, BioNTech, Bavarian Nordic - Opening Bell
    Auf die Wall Street wartet eine spannende Woche. Der Terminkalender ist pickepackevoll. Zum einen steht die Sitzung der US-​Notenbank am Mittwoch an. Zum anderen gibt es jede ...
    24.07.23 - GodmodeTrader
    BAVARIAN NORDIC - Hoch geflogen, tief gestürzt
    24.07.23 - Der Aktionär
    Bavarian Nordic: Horror‑News am Wochenende – Aktie bricht ein
    27.06.23 - GlobeNewswire
    Bavarian Nordic Reports Phase 3 Topline Results for its COVID-19 Booster Vaccine Candidate
    Booster study successfully met its primary objective, demonstrating non-​inferiority to mRNA-​vaccine Regulatory pathway will depend upon the outcome of secondary endpoints, ...
    23.06.23 - GlobeNewswire
    Bavarian Nordic to Supply Smallpox Vaccines for EU Strategic Reserve
    COPENHAGEN, Denmark, June 23, 2023 – Bavarian Nordic A/S (OMX: BAVA) announced today, that it has been awarded a contract valued at EUR 10 million to supply its smallpox ...
    20.06.23 - GlobeNewswire
    Bavarian Nordic Reports Data from a Phase 3 Clinical Trial of its VLP-Based Chikungunya Virus Vaccine in Adults ≥65 Years of Age
    Study successfully met its primary endpoints Data from second pivotal Phase 3 study in people aged 12 to 64 years expected in the third quarter 2023 COPENHAGEN, Denmark, ...

    Newssuche

    Videos

    newspaper
    25.04.24 +21,95%
    Technical Trading: S&P 500 Short Chance
    S&P 500 Short Typ: Turbo Open End WKN: NG8FUZ Hebel: 31 Laufzeit: OpenEnd Einstieg: Market ... Mehr »